Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Lipid profile in women over 35 years old using triphasic combined oral contraceptives
Author: Aldrighi, JM
Petta, CA
Bahamondes, L
Caetano, ME
Martinez, TRL
De Lima, GR
Abstract: Twenty-nine women aged 35 years old or more, using triphasic combined oral contraceptive (COC) were evaluated during six cycles for the following parameters: total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and its subfraction HDL2, triglycerides, apoproteins A and B, Castelli risk index I and II (cholesterol/HDL-C and LDL-C/HDL-C) and apoprotein ratio (apoprotein B/apoprotein A). The same laboratory measurements were done in a control group of 49 non-COC-user women. The results showed that there were no differences on most of the studied parameters between user and nonuser women. There was a significant reduction of HDL-C and LHD2-C, although within the normal range. In addition, it was observed a significant increment of triglycerides and apoprotein B at 6 months of follow-up only in user group (p < 0.05), although within the normal range. It is concluded that the use of levonorgestrel triphasic COC appeared to have no additional adverse impact when used by women aged over 35 years. Further studies are needed to obtain conclusive data. (C) 2004 Elsevier Inc. All rights reserved.
Subject: oral contraceptives
cardiovascular risk
Country: EUA
Editor: Elsevier Science Inc
Citation: Contraception. Elsevier Science Inc, v. 69, n. 5, n. 395, n. 399, 2004.
Rights: fechado
Identifier DOI: 10.1016/j.contraception.2004.01.005
Date Issue: 2004
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000221176000009.pdf65.39 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.